Advance Search
Volume 36 Issue 12
Dec.  2021
Turn off MathJax
Article Contents
DONG Wen-xue, LI Jing, ZHANG Zhi-ying, . Strategies for laboratory detection of severe acute respiratory syndrome coronavirus 2: a review[J]. Chinese Journal of Public Health, 2020, 36(12): 1838-1842. doi: 10.11847/zgggws1132725
Citation: DONG Wen-xue, LI Jing, ZHANG Zhi-ying, . Strategies for laboratory detection of severe acute respiratory syndrome coronavirus 2: a review[J]. Chinese Journal of Public Health, 2020, 36(12): 1838-1842. doi: 10.11847/zgggws1132725

Strategies for laboratory detection of severe acute respiratory syndrome coronavirus 2: a review

doi: 10.11847/zgggws1132725
  • Received Date: 2020-10-12
    Available Online: 2020-12-19
  • Publish Date: 2020-12-10
  • Nowadays, the global pandemic of coronovirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has brought a severe impact on medical environment of the world because the lack of specific treatment and early detection of SARS-CoV-2 for timely diagnosis, isolation and registration of COVID-19 cases has become an effective mean to contain the pandemic. The sensitivity of COVID-19 case diagnosis is poor based on clinical manifestations and signs of the disease, so physicians need to identify infected and non-infected persons according laboratory detection of SARS-CoV-2 nucleic acid test or other indicators. The study reviewed genomic characteristics of SARS-CoV-2 and its related detection principles. At different stages of COVID-19, the performance of different tests varied greatly. Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) based nucleic acid test is sensitive in the early and middle stage of SARS-CoV-2 infection, but serological detection, which may identify the late stage of the infection, could be used as an auxiliary detection to identify nucleic acid-negative but suspected infections. To avoid ‘false negative’ resulting in misdiagnosis or missed diagnosis, the multi-index detections should be used in laboratory detections to make up for the deficiency of a singular test.
  • loading
  • [1]
    Lu HZ, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle[J]. Journal of Medical Virology, 2020, 92(4): 401 – 402. doi: 10.1002/jmv.25678
    [2]
    Jin YH, Cai L, Cheng ZS, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)[J]. Military Medical Research, 2020, 7(1): 4. doi: 10.1186/s40779-020-0233-6
    [3]
    Li Q, Guan XH, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia[J]. The New England Journal of Medicine, 2020, 382(13): 1199 – 1207. doi: 10.1056/NEJMoa2001316
    [4]
    Elegant NX. 为何美国的新冠肺炎检测如此滞后?[J]. 中国信用, 2020(3): 118 – 120.
    [5]
    Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin[J]. Nature, 2020, 579(7798): 270 – 273. doi: 10.1038/s41586-020-2012-7
    [6]
    Ren LL, Wang YM, Wu ZQ, et al. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study[J]. Chinese Medical Journal, 2020, 133(9): 1015 – 1024. doi: 10.1097/CM9.0000000000000722
    [7]
    Chan JFW, Kok KH, Zhu Z, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan[J]. Emerging Microbes and Infections, 2020, 9(1): 221 – 236. doi: 10.1080/22221751.2020.1719902
    [8]
    Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China[J]. Nature, 2020, 579(7798): 265 – 269. doi: 10.1038/s41586-020-2008-3
    [9]
    Xu XT, Chen P, Wang JF, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission[J]. Science China Life Sciences, 2020, 63(3): 457 – 460. doi: 10.1007/s11427-020-1637-5
    [10]
    Qin ED, Zhu QY, Yu M, et al. A complete sequence and comparative analysis of a SARS-associated virus (Isolate BJ01)[J]. Chinese Science Bulletin, 2003, 48(10): 941 – 948. doi: 10.1007/BF03184203
    [11]
    秦小波, 高华, 张冰冰, 等. SARS-CoV-2核衣壳蛋白预测与原核重组表达应用[J/OL]. 生物学杂志. [2020 – 10 – 22]. https://kns.cnki.net/KCMS/detail/34.1081.Q.20200616.0915.008.html.
    [12]
    Nieto-Torres JL, DeDiego ML, Álvarez E, et al. Subcellular location and topology of severe acute respiratory syndrome coronavirus envelope protein[J]. Virology, 2011, 415(2): 69 – 82. doi: 10.1016/j.virol.2011.03.029
    [13]
    Shen ZJ, Xiao Y, Kang L, et al. Genomic diversity of severe acute respiratory syndrome-coronavirus 2 in patients with coronavirus disease 2019[J]. Clinical Infectious Diseases, 2020, 71(15): 713 – 720. doi: 10.1093/cid/ciaa203
    [14]
    Zhao WM, Song SH, Chen ML, et al. The 2019 novel coronavirus resource[J]. Yi Chuan, 2020, 42(2): 212 – 221.
    [15]
    Wang R, Hozumi Y, Zheng YH, et al. Host immune response driving SARS-CoV-2 evolution[J]. Viruses, 2020, 12(10): 1095. doi: 10.3390/v12101095
    [16]
    Pan Y, Zhang DT, Yang P, et al. Viral load of SARS-CoV-2 in clinical samples[J]. The Lancet Infectious Diseases, 2020, 20(4): 411 – 412. doi: 10.1016/S1473-3099(20)30113-4
    [17]
    Yu FT, Yan LT, Wang N, et al. Quantitative detection and viral load analysis of SARS-CoV-2 in infected patients[J]. Clinical Infectious Diseases, 2020, 71(15): 793 – 798. doi: 10.1093/cid/ciaa345
    [18]
    Young BE, Ong SWX, Kalimuddin S, et al. Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore[J]. JAMA, 2020, 323(15): 1488 – 1494. doi: 10.1001/jama.2020.3204
    [19]
    Zou LR, Ruan F, Huang MX, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients[J]. The New England Journal of Medicine, 2020, 382(12): 1177 – 1179. doi: 10.1056/NEJMc2001737
    [20]
    中华人民共和国国家卫生健康委员会办公厅, 国家中医药管理局办公室. 新型冠状病毒肺炎诊疗方案(试行第五版 修正版)[J]. 中国中西医结合杂志, 2020, 40(2): 136 – 138. doi: 10.7661/j.cjim.20200202.064
    [21]
    中华人民共和国国家卫生健康委员会办公厅, 国家中医药管理局办公室. 新型冠状病毒肺炎诊疗方案(试行第七版)[J]. 中国医药, 2020, 15(6): 801 – 805.
    [22]
    Bayley H. Nanopore sequencing: from imagination to reality[J]. Clinical Chemistry, 2015, 61(1): 25 – 31. doi: 10.1373/clinchem.2014.223016
    [23]
    Wang M, Fu AS, Hu B, et al. Nanopore targeted sequencing for the accurate and comprehensive detection of SARS-CoV-2 and other respiratory viruses[J]. Small, 2020, 16(32): 2002169. doi: 10.1002/smll.202002169
    [24]
    胡孝林, 张亮亮, 罗阳. 新型冠状病毒肺炎实验室检测策略[J]. 中华医院感染学杂志, 2020, 30(17): 2595 – 2602.
    [25]
    Hadaya J, Schumm M, Livingston EH. Testing individuals for coronavirus disease 2019 (COVID-19)[J]. JAMA, 2020, 323(19): 1981. doi: 10.1001/jama.2020.5388
    [26]
    Liu YW, Wang YY, Wang XM, et al. Development of two TaqMan real-time reverse transcription-PCR assays for the detection of severe acute respiratory syndrome coronavirus-2[J]. Biosafety and Health, 2020.
    [27]
    Padhye NS. Reconstructed diagnostic sensitivity and specificity of the RT-PCR test for COVID-19[J]. medRxiv, 2020. doi: 10.1101/2020.04.24.20078949
    [28]
    Chan WM, Ip J, Chu AWH, et al. Identification of nsp1 gene as the target of SARS-CoV-2 real-time RT-PCR using nanopore whole-genome sequencing[J]. Journal of Medical Virology, 2020, 92(11): 2725 – 2734. doi: 10.1002/jmv.26140
    [29]
    Yip CCY, Ho CC, Chan JFW, et al. Development of a novel, genome subtraction-derived, SARS-CoV-2-specific COVID-19-nsp2 real-time RT-PCR assay and its evaluation using clinical specimens[J]. International Journal of Molecular Sciences, 2020, 21(7): 2574. doi: 10.3390/ijms21072574
    [30]
    Abbasi J. The promise and peril of antibody testing for COVID-19[J]. JAMA, 2020, 323(19): 1881 – 1883. doi: 10.1001/jama.2020.6170
    [31]
    谢朝梅, 覃平, 曾希鹏, 等. 新冠肺炎确诊病例血液标本IgM和IgG动态检测结果分析[J]. 中国公共卫生, 2020, 36(10): 1396 – 1398. doi: 10.11847/zgggws1130146
    [32]
    Ma H, Zeng WH, He HL, et al. Serum IgA, IgM, and IgG responses in COVID-19[J]. Cellular and Molecular Immunology, 2020, 17(7): 773 – 775. doi: 10.1038/s41423-020-0474-z
    [33]
    Jin YJ, Wang MC, Zuo ZB, et al. Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019[J]. International Journal of Infectious Diseases, 2020, 94: 49 – 52. doi: 10.1016/j.ijid.2020.03.065
    [34]
    管红霞, 马广源, 马丹, 等. 新型冠状病毒感染核酸和抗体检测方法比较[J]. 中国公共卫生, 2020, 36(10): 1399 – 1401. doi: 10.11847/zgggws1129498
    [35]
    Cassaniti I, Novazzi F, Giardina F, et al. Performance of VivaDiag COVID-19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID-19 in acute patients referring to emergency room depart-ment[J]. Journal of Medical Virology, 2020, 92(10): 1724 – 1727. doi: 10.1002/jmv.25800
    [36]
    Infantino M, Grossi V, Lari B, et al. Diagnostic accuracy of an automated chemiluminescent immunoassay for anti-SARS-CoV-2 IgM and IgG antibodies: an Italian experience[J]. Journal of Medical Virology, 2020, 92(9): 1671 – 1675. doi: 10.1002/jmv.25932
    [37]
    Jiao L, Yan HY, Xu WQ, et al. Self-assembly of all-inclusive allochroic nanoparticles for the improved ELISA[J]. Analytical Chemistry, 2019, 91(13): 8461 – 8465. doi: 10.1021/acs.analchem.9b01527
    [38]
    Li MH, Jin RH, Peng Y, et al. Generation of antibodies against COVID-19 virus for development of diagnostic tools[J]. medRxiv, 2020.
    [39]
    Padoan A, Cosma C, Sciacovelli L, et al. Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics[J]. Clinical Chemistry and Laboratory Medicine, 2020, 58(7): 1081 – 1088. doi: 10.1515/cclm-2020-0443
    [40]
    常颜信, 徐明霖, 傅晓辉, 等. 新型冠状病毒咽拭子核酸检测法假阴性调查分析[J/OL]. 第二军医大学学报, 2020. [2020 – 05 – 22]. https://kns.cnki.net/KCMS/detail/31.1001.R.20200522.1159.002.html.
    [41]
    李浩, 王晓辉, 郑陈丽, 等. 深圳新冠肺炎出院病例核酸复检阳性特征分析[J]. 中国公共卫生, 2020, 36(10): 1393 – 1395. doi: 10.11847/zgggws1130167
    [42]
    常颜信, 徐明霖, 傅晓辉, 等. 严重急性呼吸综合征冠状病毒2咽拭子核酸检测法假阴性调查分析[J]. 第二军医大学学报, 2020, 41(6): 592 – 595.
    [43]
    Wang YS, Kang HYJ, Liu XF, et al. Combination of RT-qPCR testing and clinical features for diagnosis of COVID-19 facilitates management of SARS-CoV-2 outbreak[J]. Journal of Medical Virology, 2020, 92(6): 538 – 539. doi: 10.1002/jmv.25721
    [44]
    Feng H, Liu YJ, Lv ML, et al. A case report of COVID-19 with false negative RT-PCR test: necessity of chest CT[J]. Japanese Journal of Radiology, 2020, 38(5): 409 – 410. doi: 10.1007/s11604-020-00967-9
    [45]
    Ai T, Yang ZL, Hou HY, et al. Correlation of chest CT and RT-PCR testing for coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases[J]. Radiology, 2020, 296(2): E41 – E45. doi: 10.1148/radiol.2020200343
    [46]
    Mardani R, Vasmehjani AA, Zali F, et al. Laboratory parameters in detection of COVID-19 patients with positive RT-PCR; a diagnostic accuracy study[J]. Archives of Academic Emergency Medicine, 2020, 8(1): e43.
    [47]
    李佳, 李霖, 李春辉, 等. 咽拭子新型冠状病毒核酸检测的临床价值[J]. 中国感染控制杂志, 2020, 19(7): 585 – 590. doi: 10.12138/j.issn.16719638.20206562
    [48]
    上海市医学会检验医学分会. 新型冠状病毒核酸和抗体检测临床应用专家共识[J]. 国际检验医学杂志, 2020, 41(14): 1665 – 1669. doi: 10.3969/j.issn.1673-4130.2020.14.001
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)

    Article views (3803) PDF downloads(76) Cited by()
    Proportional views
    Publishing history
    • Receive:  2020-10-12
    • Online:  2020-12-19
    • Published:  2020-12-10

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return